BCL2L1 and plasma cell myeloma: Bcl‐2, Bcl‐xL, and Mcl‐1 are significantly overexpressed in myeloma cells, and are considered to be among the major contributing factors to the survival, growth, and chemo‐resistance of myeloma.32, 34 Therefore, targeting these proteins represents an attractive therapeutic strategy.